4.6 Review

Inflammation, Coagulation, and the Pathway to Frailty

Journal

AMERICAN JOURNAL OF MEDICINE
Volume 122, Issue 7, Pages 605-613

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/j.amjmed.2009.01.030

Keywords

Coagulation; Cytokines; D-dimer; Frailty; Inflammation; Interleukin-6; Sarcopenia; Tumor necrosis factor-alpha

Funding

  1. Intramural Research Program, National Institute on Aging (National Institutes of Health)

Ask authors/readers for more resources

There are inevitable physiologic changes associated with advancing age, yet for some people these changes are exaggerated, and as a result a phenotype emerges recognized as frailty. Why some people become frail and others do not remains incompletely understood. Although chronic illnesses are common among frail elderly persons, some will develop all of the phenotypic features without a diagnosed underlying disease. It has been recognized that certain proinflammatory cytokines and coagulation factors are elevated to a greater extent in those who are frail than in age-matched nonfrail individuals. In this review, we provide an overview of current research in the biology of frailty with particular emphasis on the role of inflammatory pathways and disordered coagulation in its pathogenesis. Published by Elsevier Inc. The American Journal of Medicine (2009) 122, 605-613

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available